CLAIM CARD
Within the corpus, significant tensions exist regarding the efficacy of CGM and glucose variability interventions. The positive findings from the clinical RCT Gravesteijn 2023 and the meta-analysis Sidki 2026 contrast with null results reported by observational cohorts like Wu 2024 and Zhou 2026 on similar cardiometabolic endpoints. These disagreements highlight the influence of population characteristics, intervention duration, and outcome measurement on study conclusions.
Evidence grade: exploratory
Contradiction status: none
Publication: becb4785-6244-41cd-ba08-c47e58dca346
Provenance: Derivation Web chain
Citation Support
source_1Sidki 2026source_2Gravesteijn 2023source_3Lu 2021source_4Lee 2020source_5Franceschi 2026